Latest News and Press Releases
Want to stay updated on the latest news?
-
The complaint alleges Blue Owl hid BDC-redemption pressure, liquidity issues, and likely redemption limits, making its positive statements misleading.
-
The complaint alleges Cepton hid a higher bid, failed to evaluate or disclose it, depriving shareholders of a fair choice and making statements misleading.
-
The complaint alleges Marex sold OTC instruments to itself, had major financial inconsistencies, issued unreliable financials, and misled investors.
-
The complaint alleges defendants overstated Efzofitimod’s efficacy, hid steroid-taper issues, and inflated aTyr’s stock through these misstatements.
-
NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
-
NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
-
NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
-
NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
-
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
-
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc....